Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX Showing element 2558 to 2607 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELONGATION FACTOR 2 (EF-2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.432107\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.01624\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214313276\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EEF2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.128297\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.598643\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214313038\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CEP164\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2560\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING FAMILY A MEMBER 1 (NEURON- SPECIFIC X11 PROTEIN) (NEURONAL MUNC18-1-INTERACTING PROTEIN 1) (MINT-1) (ADAPTER PROTEIN X11ALPHA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.16418\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.766097\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214307066\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
APBA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2561\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"28S RIBOSOMAL PROTEIN S18A, MITOCHONDRIAL PRECURSOR (MRP-S18-A) (MRPS18A) (MRP-S18-3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0319993\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.149576\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213933385\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MRPS18A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2562\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATP SYNTHASE ALPHA CHAIN, MITOCHONDRIAL PRECURSOR (EC 3.6.3.14). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.383439\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.79234\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213932066\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP5A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2563\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
14-3-3 PROTEIN BETA/ALPHA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1) (PROTEIN 1054). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.286436\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.34026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213716742\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
YWHAB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2564\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLUTAMINE SYNTHETASE (EC 6.3.1.2) (GLUTAMATE--AMMONIA LIGASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.174535\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.8167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213707604\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GLUL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TETRATRICOPEPTIDE REPEAT PROTEIN 4 (MY044 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.061947\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.290115\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213525671\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2566\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-HYDROXYISOBUTYRYL-COENZYME A HYDROLASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.512064\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.39827\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213513908\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2567\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0789696\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.370007\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213427314\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZYG11B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2568\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HISTONE DEACETYLASE 5 (HD5) (ANTIGEN NY-CO-9). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.078494\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.367782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213425344\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HDAC5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2569\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HISTONE DEACETYLASE 4 (HD4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0642768\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.301176\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213419396\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HDAC4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2570\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HISTONE DEACETYLASE 9 (HD9) (HD7B) (HD7). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.06311\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.29571\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213418552\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HDAC9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER (NA(+)-DEPENDENT MULTIVITAMIN TRANSPORTER). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.248255\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.16362\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213347141\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC5A6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SOLUTE CARRIER FAMILY 5 (IODIDE TRANSPORTER), MEMBER 8; APICAL IODIDE TRANSPORTER. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.257307\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.20606\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213345107\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC5A8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2573\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KIDNEY AND LIVER PROLINE OXIDASE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0574606\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.269336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2133417\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRODH2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2574\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0577101\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.270506\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213341294\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SODIUM/IODIDE COTRANSPORTER (NA(+)/I(-) COTRANSPORTER) (SODIUM-IODIDE SYMPORTER) (NA+/I-SYMPORTER). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.30514\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.43033\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213335384\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC5A5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
14-3-3 PROTEIN ZETA/DELTA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1) (FACTOR ACTIVATING EXOENZYME S) (FAS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.354694\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.66376\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2131882\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
YWHAZ\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SERINE PROTEASE HTRA2, MITOCHONDRIAL PRECURSOR (EC 3.4.21.-) (HIGH TEMPERATURE REQUIREMENT PROTEIN A2) (HTRA2) (OMI STRESS-REGULATED ENDOPROTEASE) (SERINE PROTEINASE OMI). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.4666\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.18902\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213154745\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HTRA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2578\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROBABLE SERINE PROTEASE HTRA4 PRECURSOR (EC 3.4.21.-). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.491713\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.30709\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213131261\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HTRA4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2579\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROBABLE SERINE PROTEASE HTRA3 PRECURSOR (EC 3.4.21.-). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.498067\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.33696\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213126027\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HTRA3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BLOOD GROUP RH(CE) POLYPEPTIDE (RHESUS C/E ANTIGENS) (RH30A) (RHIXB) (RH POLYPEPTIDE 1) (RHPI). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0564693\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.264963\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.213121455\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BLOOD GROUP RH(D) POLYPEPTIDE (RHESUS D ANTIGEN) (RHXIII) (RH POLYPEPTIDE 2) (RHPII). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
RHD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2582\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BLOOD GROUP RH(CE) POLYPEPTIDE (RHESUS C/E ANTIGENS) (RH30A) (RHIXB) (RH POLYPEPTIDE 1) (RHPI). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0561617\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.26352\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213121205\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHESUS BLOOD GROUP-ASSOCIATED GLYCOPROTEIN (ERYTHROCYTE PLASMA MEMBRANE 50 KDA GLYCOPROTEIN) (RH50A). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.062927\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.295267\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213118974\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RHAG\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"RHESUS BLOOD GROUP, B GLYCOPROTEIN; RH TYPE B GLYCOPROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0646696\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.303444\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.21311873\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RHBG\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RH TYPE C GLYCOPROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.077662\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.364414\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213114754\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RHCG\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE PROTEASE HTRA1 PRECURSOR (EC 3.4.21.-) (L56). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.574918\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.69828\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.213068325\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HTRA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYOFIBRILLOGENESIS REGULATOR 1; TRANS-ACTIVATED BY HEPATITIS C VIRUS CORE PROTEIN 2; LIKELY ORTHOLOG OF MOUSE BRAIN PROTEIN 17. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.48801\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.292\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212918848\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PNKD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.526405\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.47257\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212897916\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HAGHL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (SOLUTE CARRIER FAMILY 25, MEMBER 13) (CITRIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0223249\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.104865\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212891813\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC25A13\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DC11 PROTEIN. \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0255653\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.120086\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.212891594\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MELANOMA ANTIGEN RECOGNIZED BY T CELLS 2. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
HHAT\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEPATITIS C VIRUS CORE-BINDING PROTEIN 6; CERVICAL CANCER ONCOGENE 3. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR1 (SOLUTE CARRIER FAMILY 25, MEMBER 12). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0255652\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
0.212890762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC25A12\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"UBIQUITIN-ACTIVATING ENZYME E1C (UBA3 HOMOLOG, YEAST); UBIQUITIN-ACTIVATING ENZYME E1C (HOMOLOGOUS TO YEAST UBA3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0734554\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.345038\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212890754\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UBE1C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ACYL CARRIER PROTEIN, MITOCHONDRIAL PRECURSOR (ACP) (NADH-UBIQUINONE OXIDOREDUCTASE 9.6 KDA SUBUNIT) (CI-SDAP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.929425\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.36574\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212890598\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NDUFAB1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"5-AMINOLEVULINIC ACID SYNTHASE, NONSPECIFIC, MITOCHONDRIAL PRECURSOR (EC 2.3.1.37) (DELTA-AMINOLEVULINATE SYNTHASE) (DELTA-ALA SYNTHETASE) (ALAS-H). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0634018\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.297814\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212890596\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ALAS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AMYLOID BETA PRECURSOR PROTEIN-BINDING PROTEIN 1; AMYLOID PROTEIN-BINDING PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0719023\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.337743\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212890571\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
APPBP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0200176\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0940277\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212890457\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HHATL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"5-AMINOLEVULINIC ACID SYNTHASE, ERYTHROID-SPECIFIC, MITOCHONDRIAL PRECURSOR (EC 2.3.1.37) (DELTA-AMINOLEVULINATE SYNTHASE) (DELTA-ALA SYNTHETASE) (ALAS-E). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0766446\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.360019\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212890431\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ALAS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBIQUITIN-ACTIVATING ENZYME E1 (A1S9 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.046337\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.217657\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212890006\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UBE1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YL-1 PROTEIN (TRANSCRIPTION FACTOR-LIKE 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0253936\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.119307\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212842499\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS72\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HYDROXYACYLGLUTATHIONE HYDROLASE (EC 3.1.2.6) (GLYOXALASE II) (GLX II). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.687702\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.23104\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212842305\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HAGH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DYSKERIN (NUCLEOLAR PROTEIN NAP57) (CBF5 HOMOLOG). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.95535\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.50581\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.212026251\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DKC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ACETYL-COA ACETYLTRANSFERASE, MITOCHONDRIAL PRECURSOR (EC 2.3.1.9) (ACETOACETYL-COA THIOLASE) (T2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.663698\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.13139\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.211949965\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACAT1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"HYDROXYMETHYLGLUTARYL-COA SYNTHASE, MITOCHONDRIAL PRECURSOR (EC 2.3.3.10) (HMG-COA SYNTHASE) (3-HYDROXY-3-METHYLGLUTARYL COENZYME A SYNTHASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0635814\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.299985\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.211948597\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HMGCS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (EC 1.1.1.34) (HMG-COA REDUCTASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0963713\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.454692\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.211948528\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HMGCR\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"HYDROXYMETHYLGLUTARYL-COA SYNTHASE, CYTOPLASMIC (EC 2.3.3.10) (HMG-COA SYNTHASE) (3-HYDROXY-3-METHYLGLUTARYL COENZYME A SYNTHASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0751775\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.354697\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.211948508\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HMGCS1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots

- http://analysis.yellowcouch.org/